Abstract <p>Depression is the most common mental illness. The etiopathogenesis of depression and the mechanisms of action of antidepressants remain poorly understood. Accumulating evidence indicates the involvement of neurotrophic factors (NTFs) in the development of depression and the effects of antidepressants. Chronic stress is a risk factor for depression and leads to decreased NTF levels in several brain regions. The effects of chronic glucocorticoid and antidepressant exposure on NTF expression in astrocytes remains largely unexplored. The aim of this study was to evaluate the effects of corticosterone at stress concentration and antidepressants on the expression of depression- or antidepressant-related NTFs in astrocytes in vitro. Cultured rat C6 astrocytoma cells have been used. Serum-free culture medium has been supplemented with corticosterone at basal (0.1 μM) or stress (1 μM) concentrations, with amitriptyline (25 μM), or fluoxetine (10 μM) once or for seven days. After 24 h BDNF, NGF, VEGF, and S100β mRNA were assessed using real-time PCR. Corticosterone (1 μM) stimulated BDNF expression both acutely and chronically. Stimulation of NGF and S100β expression and suppression of VEGF expression were observed only with chronic exposure. Both antidepressants stimulated BDNF and NGF expression only with chronic exposure and only at basal corticosterone concentration. Antidepressants increased VEGF expression during chronic exposure to both concentrations of corticosterone. These data demonstrate that corticosterone at stress concentration regulates the expression of depression-associated NTFs in C6 cells. These results may reflect the neuroprotective role of astrocytes during stress, the involvement of astrocytes in the therapeutic effects of antidepressants, and can be used to develop cell models to study the mechanisms of stress effects on the central nervous system and to test compounds with potential antidepressant activity.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Effects of Corticosterone and the Antidepressants Fluoxetine and Amitriptyline on the Expression of Neurotrophic Factors in Rat Astrocytoma C6 Cells

  • A. N. Novozhenova,
  • O. V. Dolotov,
  • I. A. Grivennikov

摘要

Abstract

Depression is the most common mental illness. The etiopathogenesis of depression and the mechanisms of action of antidepressants remain poorly understood. Accumulating evidence indicates the involvement of neurotrophic factors (NTFs) in the development of depression and the effects of antidepressants. Chronic stress is a risk factor for depression and leads to decreased NTF levels in several brain regions. The effects of chronic glucocorticoid and antidepressant exposure on NTF expression in astrocytes remains largely unexplored. The aim of this study was to evaluate the effects of corticosterone at stress concentration and antidepressants on the expression of depression- or antidepressant-related NTFs in astrocytes in vitro. Cultured rat C6 astrocytoma cells have been used. Serum-free culture medium has been supplemented with corticosterone at basal (0.1 μM) or stress (1 μM) concentrations, with amitriptyline (25 μM), or fluoxetine (10 μM) once or for seven days. After 24 h BDNF, NGF, VEGF, and S100β mRNA were assessed using real-time PCR. Corticosterone (1 μM) stimulated BDNF expression both acutely and chronically. Stimulation of NGF and S100β expression and suppression of VEGF expression were observed only with chronic exposure. Both antidepressants stimulated BDNF and NGF expression only with chronic exposure and only at basal corticosterone concentration. Antidepressants increased VEGF expression during chronic exposure to both concentrations of corticosterone. These data demonstrate that corticosterone at stress concentration regulates the expression of depression-associated NTFs in C6 cells. These results may reflect the neuroprotective role of astrocytes during stress, the involvement of astrocytes in the therapeutic effects of antidepressants, and can be used to develop cell models to study the mechanisms of stress effects on the central nervous system and to test compounds with potential antidepressant activity.